Medical News

RSS

EntreMed announces publication of ENMD-2076 Phase 1 results against solid tumors in AACR journal

EntreMed, Inc., today announced the publication of key papers on the clinical and preclinical development of ENMD-2076, an Aurora A/angiogenic kinase inhibitor. The clinical data were published in the December 3, 2010 on-line issue of the American Association for Cancer Research journal, Clinical Cancer Research, and are expected to appear soon in the print version of the publication.

4 Feb 2011

General Dynamics to collaborate with MPT to offer EHR solution to DoD

General Dynamics Information Technology, a business unit of General Dynamics, has entered into a letter of intent with McKesson Provider Technologies to collaborate in offering an Electronic Health Record solution known as the "Way Ahead" to the Department of Defense.

4 Feb 2011

Savient closes sale of $230M 4.75% Convertible Senior Notes due 2018

Savient Pharmaceuticals, Inc. today announced the closing of its sale of $230 million aggregate principal amount of 4.75% Convertible Senior Notes due 2018 (the "Notes"). The aggregate principal amount of Notes sold reflects the full exercise by the underwriters of their option to purchase $30 million principal amount of Notes to cover over-allotments.

4 Feb 2011

MedQuist Holdings prices initial public offering of common stock at $8.00 per share

MedQuist Holdings Inc., formerly CBaySystems Holdings Limited, a leading provider of integrated clinical documentation solutions for the U.S. Healthcare system, today announced the pricing of its U.S. initial public offering of 4,500,000 shares of its common stock at a price to the public of $8.00 per share.

4 Feb 2011

ECR launches sleep aid product, Zolpimist Oral Spray in the US

NovaDel Pharma Inc. today announced that Zolpimist Oral Spray has been launched in the United States by ECR Pharmaceuticals, a subsidiary of Hi-Tech Pharmacal Co., Inc.. ECR Pharmaceuticals announced the immediate availability of Zolpimist Oral Spray, a novel delivery system of the most widely prescribed sleep aid in the US, zolpidem tartrate.

4 Feb 2011

FDA clears new mobile radiology application

A new mobile radiology application cleared today by the U.S. Food and Drug Administration will allow physicians to view medical images on the iPhone and iPad manufactured by Apple Inc.

4 Feb 2011

Hologic receives FDA approval for hydroxyprogesterone caproate injection

Hologic, a leading developer, manufacturer and supplier of premium diagnostics products, medical imaging systems and surgical products dedicated to serving the healthcare needs of women, announced today the U.S. Food and Drug Administration has approved Hologic's pharmaceutical named Makena, formerly known as Gestiva.

From Hologic, Inc. 4 Feb 2011

Research roundup: Comparing profit and nonprofit hospice care; Hospital mortality and spending; High-deductible insurance plans

Association Of Hospice Agency Profit Status With Patient Diagnosis, Location of Care, and Length of Stay - "The current Medicare Hospice Benefit reimburses hospices at a fixed per diem rate that does not consider the patient's diagnosis, location of care, or hospice LOS [length-of-stay]," and as such, "profit can be maximized by caring for patients with certain diagnoses that require fewer skilled services, patients residing in nursing homes, or patients with longer hospice stays."

4 Feb 2011

Incisive Surgical, Innocutis sign marketing agreement for INSORB Absorbable Skin Stapler

Innocutis Medical, a dermatology company focused on novel surgical devices and specialty pharmaceuticals, is pleased to announce an exclusive marketing agreement with Incisive Surgical, for the sales and marketing rights within the dermatology market for the patented INSORB Absorbable Skin Stapler, a revolutionary new modality for skin closure.

4 Feb 2011

Dermatologists offer preventative tips to minimize pesky skin problems caused by plants

What may start as a seemingly harmless day of gardening or yard work can quickly take a turn for the worse when common plants make their mark on the skin, causing a host of mild to even severe skin reactions. That is why dermatologists are arming outdoor enthusiasts with preventative tips to keep these perils of the great outdoors at arm's length.

4 Feb 2011

ECR announces availability of Zolpimist Oral Spray in the U.S.

ECR Pharmaceuticals Co., Inc., a subsidiary of Hi-Tech Pharmacal Co., Inc. announced the immediate availability of Zolpimist Oral Spray, a novel delivery system of the most widely prescribed sleep aid in the US, zolpidem tartrate.

4 Feb 2011

Scientists discover how stressed cells boost thrombin production

In our not-so-distant evolutionary past, stress often meant imminent danger, and the risk of blood loss, so part of our body's stress response is to stock-pile blood-clotting factors. Scientists in the Molecular Medicine Partnership Unit, a collaboration between the European Molecular Biology Laboratory in Heidelberg, Germany, and the University of Heidelberg Medical Centre, have discovered how stressed cells boost the production of the key blood-clotting factor, thrombin.

4 Feb 2011

BIOTRONIK launches Reliaty pacing system analyzer in Europe

BIOTRONIK SE & Co. KG, today announced the European launch of the Reliaty pacing system analyzer after CE approval and successful pre-market evaluation. The pacing system analyzer is used during an implantation of implantable pacemakers, implantable cardioverter-defibrillators and Cardiac Resynchronization Therapy systems to ensure adequate lead placement, maintenance of basic cardiac functions, and to evaluate pacing parameters for customized device programming.

4 Feb 2011

Governors get advice from Obama administration on how to handle Medicaid

HHS Secretary Kathleen Sebelius provided information Thursday to state officials explaining ways in which current law allows them to change the federal-state program — to gain savings without slashing eligibility.

4 Feb 2011

BG Medicine prices initial public offering of 5,000,000 shares of common stock

BG Medicine today announced the pricing of its initial public offering of 5,000,000 shares of its common stock at a price of $7.00 per share, before underwriting discounts and commissions. All shares are being sold by the Company.

4 Feb 2011

Accelerated completes acquisition of SPTRS, Burkam

Gryphon Investors announced today that its outpatient physical therapy platform company, Accelerated Rehabilitation Centers, has completed the acquisition of two physical therapy companies - Wisconsin based Sports Physical Therapy & Rehab Specialists and Ohio based Burkam & Associates.

4 Feb 2011

Salk Institute receives $2.3 million CIRM grant for translational research on Parkinson's disease

The Salk Institute has been awarded a $2.3 million grant by the California Institute for Regenerative Medicine for translational research focusing on developing a novel stem cell based therapy for Parkinson's disease.

4 Feb 2011

DaVita enters definitive agreement to acquire DSI Renal for $690 million

DaVita, announced that it has entered into a definitive agreement to acquire DSI Renal, for approximately $690 million, subject to adjustments. The company expects to close the transaction in the second or third quarter of this year.

4 Feb 2011

Scientists awarded grant to study microbiology of Cystic Fibrosis pulmonary infection

Scientists at Queen's University Belfast have begun work into improving the lives of thousands of Cystic Fibrosis sufferers thanks to the award of a -1.74 million US-Ireland Research and Development Partnership grant.

4 Feb 2011

First Edition: February 4, 2011

Today's headlines include reports that Virginia's attorney general is asking the Supreme Court to expedite its review of the state's challenge to the health law. Meanwhile, the Obama administration is doling out advice to governors about how to handle Medicaid.

4 Feb 2011

Medical News

EntreMed announces publication of ENMD-2076 Phase 1 results against solid tumors in AACR journal

General Dynamics to collaborate with MPT to offer EHR solution to DoD

Savient closes sale of $230M 4.75% Convertible Senior Notes due 2018

MedQuist Holdings prices initial public offering of common stock at $8.00 per share

ECR launches sleep aid product, Zolpimist Oral Spray in the US

FDA clears new mobile radiology application

Hologic receives FDA approval for hydroxyprogesterone caproate injection

Research roundup: Comparing profit and nonprofit hospice care; Hospital mortality and spending; High-deductible insurance plans

Incisive Surgical, Innocutis sign marketing agreement for INSORB Absorbable Skin Stapler

Dermatologists offer preventative tips to minimize pesky skin problems caused by plants

ECR announces availability of Zolpimist Oral Spray in the U.S.

Scientists discover how stressed cells boost thrombin production

BIOTRONIK launches Reliaty pacing system analyzer in Europe

Governors get advice from Obama administration on how to handle Medicaid

BG Medicine prices initial public offering of 5,000,000 shares of common stock

Accelerated completes acquisition of SPTRS, Burkam

Salk Institute receives $2.3 million CIRM grant for translational research on Parkinson's disease

DaVita enters definitive agreement to acquire DSI Renal for $690 million

Scientists awarded grant to study microbiology of Cystic Fibrosis pulmonary infection

First Edition: February 4, 2011

Advancing brain microphysiological systems (bMPS)

PhD researcher at LifeArc

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

Latest News